Maas, Silvana C. E.
Mens, Michelle M. J.
Kühnel, Brigitte
van Meurs, Joyce B. J.
Uitterlinden, André G.
Peters, Annette
Prokisch, Holger
Herder, Christian
Grallert, Harald
Kunze, Sonja
Waldenberger, Melanie
Kavousi, Maryam
Kayser, Manfred
Ghanbari, Mohsen https://orcid.org/0000-0002-9476-7143
Funding for this research was provided by:
Erasmus Medisch Centrum
Erasmus Universiteit Rotterdam
ZonMw
the Research Institute for Diseases in the Elderly
the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports
European Commission
Municipality of Rotterdam
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (184021007)
the German Federal Ministry of Education and Research
the State of Bavaria
Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universität, Munich, Germany, as part of LMUinnovativ
Ministry of Culture and Science of the State of North Rhine-Westphalia and the German Federal Ministry of Health
Article History
Received: 6 July 2020
Accepted: 13 October 2020
First Online: 22 October 2020
Ethics approval and consent to participate
: The Rotterdam Study was approved by the institutional review boards of the Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and by the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272-159521-PG). The Rotterdam Study has been entered into the Netherlands National Trial Register (NTR; ) and into the WHO International Clinical Trials Registry Platform (ICTRP; ) under shared catalogue number NTR6831. The KORA study was approved by the Institutional review board Ethics Committee of the Bavarian Medical Association (Bayrische Landesärztekammer). All participants included in the current study provided written informed consent to participate in the study and to have their information obtained from treating physicians. The experimental methods comply with the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.